87 related articles for article (PubMed ID: 20602622)
1. Rituximab-induced acute severe thrombocytopenia.
Parajuli R; Hire E; Shah BK
Br J Haematol; 2010 Jun; 149(6):804. PubMed ID: 20602622
[No Abstract] [Full Text] [Related]
2. Rituximab-induced severe acute thrombocytopenia: a case report and review of literature.
Dhand S; Bahrain H
Cancer Invest; 2008 Nov; 26(9):913-5. PubMed ID: 19034773
[TBL] [Abstract][Full Text] [Related]
3. Rituximab-induced acute severe thrombocytopenia: a case series in patients with mantle cell lymphoma.
Sadashiv SK; Rao R; Fazal S; Lister J
Clin Lymphoma Myeloma Leuk; 2013 Oct; 13(5):602-5. PubMed ID: 23870855
[No Abstract] [Full Text] [Related]
4. Rituximab-associated acute thrombocytopenia: an under-diagnosed phenomenon.
Ram R; Bonstein L; Gafter-Gvili A; Ben-Bassat I; Shpilberg O; Raanani P
Am J Hematol; 2009 Apr; 84(4):247-50. PubMed ID: 19260124
[TBL] [Abstract][Full Text] [Related]
5. Rituximab-induced acute thrombocytopenia: a report of two cases.
Otrock ZK; Mahfouz RA; Oghlakian GO; Salem ZM; Bazarbachi A
Haematologica; 2005 Nov; 90 Suppl():ECR23. PubMed ID: 16266914
[TBL] [Abstract][Full Text] [Related]
6. Ventricular tachycardia associated with infusion of rituximab in mantle cell lymphoma.
Arai Y; Tadokoro J; Mitani K
Am J Hematol; 2005 Apr; 78(4):317-8. PubMed ID: 15795913
[No Abstract] [Full Text] [Related]
7. Rituximab-induced acute thrombocytopenia in a patient with prolymphocytic leukemia.
Pamuk GE; Donmez S; Turgut B; Demir M; Vural O
Am J Hematol; 2005 Jan; 78(1):81. PubMed ID: 15609288
[No Abstract] [Full Text] [Related]
8. Interstitial pneumonitis related to rituximab therapy.
Burton C; Kaczmarski R; Jan-Mohamed R
N Engl J Med; 2003 Jun; 348(26):2690-1; discussion 2690-1. PubMed ID: 12826649
[No Abstract] [Full Text] [Related]
9. Serum sickness following treatment with rituximab.
Todd DJ; Helfgott SM
J Rheumatol; 2007 Feb; 34(2):430-3. PubMed ID: 17295433
[TBL] [Abstract][Full Text] [Related]
10. Late-onset neutropenia following viral bone marrow depression after rituximab therapy.
Christopeit M; Haak U; Behre G
Ann Hematol; 2008 Sep; 87(9):761-2. PubMed ID: 18350295
[No Abstract] [Full Text] [Related]
11. Case report of rituximab-induced thrombocytopenia.
Shah C; Grethlein SJ
Am J Hematol; 2004 Apr; 75(4):263. PubMed ID: 15054827
[No Abstract] [Full Text] [Related]
12. Rituximab-induced haemorrhagic thrombocytopenia in a patient with hairy cell leukaemia.
Thachil J; Mukherje K; Woodcock B
Br J Haematol; 2006 Oct; 135(2):273-4. PubMed ID: 16965386
[No Abstract] [Full Text] [Related]
13. Severe hematological side effects following Rituximab therapy in children.
Larrar S; Guitton C; Willems M; Bader-Meunier B
Haematologica; 2006 Aug; 91(8 Suppl):ECR36. PubMed ID: 16923520
[TBL] [Abstract][Full Text] [Related]
14. Severe thrombocytopenia and fibrinolysis mimicking disseminated intravascular coagulation after rituximab infusion.
Kotsianidis I; Goutzouvelidis A; Anastasiades A; Bouchliou I; Nakou E; Spanoudakis E; Christophoridou AV; Margaritis D; Bourikas G; Tsatalas C
Am J Hematol; 2010 Feb; 85(2):146. PubMed ID: 20052746
[No Abstract] [Full Text] [Related]
15. Depletion of B lymphocytes from cerebral perivascular spaces by rituximab.
Martin Mdel P; Cravens PD; Winger R; Kieseier BC; Cepok S; Eagar TN; Zamvil SS; Weber MS; Frohman EM; Kleinschmidt-Demasters BK; Montine TJ; Hemmer B; Marra CM; Stüve O
Arch Neurol; 2009 Aug; 66(8):1016-20. PubMed ID: 19667224
[TBL] [Abstract][Full Text] [Related]
16. Factors predictive for response of follicular and mantle-cell lymphoma to rituximab.
Pfreundschuh M
Nat Clin Pract Oncol; 2006 Apr; 3(4):184-5. PubMed ID: 16596141
[No Abstract] [Full Text] [Related]
17. [New data prove therapeutic superiority. MabThera in follicular and mantle cell lymphoma].
Krankenpfl J; 2002; 40(5-6):161. PubMed ID: 12271501
[No Abstract] [Full Text] [Related]
18. Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma.
Wang M; Fayad L; Cabanillas F; Hagemeister F; McLaughlin P; Rodriguez MA; Kwak LW; Zhou Y; Kantarjian H; Romaguera J
Cancer; 2008 Nov; 113(10):2734-41. PubMed ID: 18973182
[TBL] [Abstract][Full Text] [Related]
19. Concurrent involved field radiation therapy and temsirolimus in refractory mantle cell lymphoma (MCL).
Kirova YM; Chargari C; Amessis M; Vernant JP; Dhedin N
Am J Hematol; 2010 Nov; 85(11):892. PubMed ID: 20721889
[No Abstract] [Full Text] [Related]
20. Monoclonal antibodies for the treatment of hematologic malignancies: clinical trials in Japan.
Tobinai K
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S90-6. PubMed ID: 12819934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
